Array Technologies ( NASDAQ: ARRY) on Friday was downgraded to Underperform from Neutral by analysts at Bank of America who cited heightened margin risks and limited near-term catalysts.

Abstract: A novel refractive index (RI) plasmonic biosensor with high sensitivity for human blood group detection is proposed and numerically investigated in the visible and near-infrared (NIR) regime ...

Subscribe Login Register Log out My Profile Subscriber Services Search EBLADE ENTER-TO-WIN BLADE REWARDS BLADE VAULT / REPRINTS OBITUARIES JOBS CLASSIFIEDS BLADE HOMES HOMES WEEKLY ADS EVENTS CONTACT ...